TCON
Tracon Pharmaceuticals, Inc.
No insider bought or sold Tracon Pharmaceuticals, Inc. in the last 12 months
TCON over the last year
Prices for TCON aren't in yet.
TCON after insider buys
3 months after each buy, from the first price a copier could get.
4 buys since 2018 with 3 months of prices.
Every filing
34 insider filings since 2018, newest first
Charles Theuer · President and CEO
Opaleye Management Inc. · 10% owner
Opaleye Management Inc. · 10% owner
Charles Theuer · President and CEO
Opaleye Management Inc. · 10% owner
Opaleye Management Inc. · 10% owner
Opaleye Management Inc. · 10% owner
Opaleye Management Inc. · 10% owner
Opaleye Management Inc. · 10% owner
Opaleye Management Inc. · 10% owner
Opaleye Management Inc. · 10% owner
Charles Theuer · President and CEO
Ikarian Capital, LLC · Member of 10% Group, 10%
Opaleye Management Inc. · 10% owner
Ikarian Capital, LLC · Member of 10% Group, 10%
Charles Theuer · President and CEO
Opaleye Management Inc. · 10% owner
Opaleye Management Inc. · 10% owner
Charles Theuer · President and CEO
Charles Theuer · President and CEO
Charles Theuer · President and CEO
Charles Theuer · President and CEO
Puissance Cross-Border Opportunities V LLC · 10% owner
Charles Theuer · President and CEO
Ravi Viswanathan · 10% owner
Peter W. Sonsini · 10% owner
Scott D Sandell · 10% owner
David M Mott · 10% owner
Patrick J Kerins · 10% owner
Anthony A. Florence Jr. · 10% owner
Forest Baskett · 10% owner
Peter J Barris · 10% owner
M James Barrett · 10% owner
New Enterprise Associates 14, L.P. · 10% owner
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.